Halozyme Therapeutics Inc (NASDAQ:HALO)

15.30
Delayed Data
As of Apr 17
 -0.22 / -1.42%
Today’s Change
6.88
Today|||52-Week Range
16.55
+58.55%
Year-to-Date

Today’s Trading

Previous close15.52
Today’s open15.37
Day’s range15.08 - 15.55
Volume811,304
Average volume (3 months)1,472,566
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+10.41%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book47.18

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp-1.23-2.37%
NVAXNovavax Inc-0.16-1.94%
FMIFoundation Medicine ...-0.38-0.76%
ESPREsperion Therapeutic...-0.13-0.12%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers